Nephrology

Hypertension and nephrology

DECEMBER 18, 2023

[The Hungarian Kidney Foundation "Lifetime Achievement Award for Nephrology" László Szalay]

[He was awarded the 2023 Lifetime Achievement Award for Nephrology by the Hungarian Kidney Foundation, which was presented by Professor László Rosivall at the XXXVIII General Meeting of the Hungarian Nephrology Society in Eger, Hungary.]

HUN 2023;27(06)

Hypertension and nephrology

DECEMBER 18, 2023

[The Master is gone, but his rich legacy remains with us]

ROSIVALL László

[The 93-year-old doyen of Hungarian nephrology, Prof. Dr. János Radó, has passed away, but his rich legacy lives on with us.]

HUN 2023;27(06)

Hypertension and nephrology

DECEMBER 18, 2023

[I was president of the Hungarian Nephrology Society...]

ROSIVALL László

[I was honoured to represent MANET - of which I am a founding member, and whose many committees I have chaired, chair, or serve on to this day - to serve as President between 2020 and 2023, at a time when unprecedented and unanticipated storms have whipped up and made progress difficult.]

HUN 2023;27(06)

Clinical Neuroscience

NOVEMBER 30, 2023

The significance of neutrophil/lympocyte ratio and platelet/lymphocyte ratio in predicting diabetic polyneuropathy and neuropathic pain severity as inflammatory factors

MUSTAFA TERZI, OZLEM ETHEMOGLU, MEHMET Ali EREN, ÖZCAN KOCATÜRK

Neuropathic pain may appear as one of the first symptoms that take the patient to the physician in type 2 diabetes, which can be asymptomatic for years. Although it is accepted that diabetes is a trigger for vascular inflammation, it has been suggested that inflammation itself may trigger diabetes. In our study, we aimed to investigate the relationship between diabetic polyneuropathy and neuropathic pain and inflammatory markers.

ENG 2023;76(11-12)

Clinical Neuroscience

NOVEMBER 30, 2023

Pembrolizumab-induced peripheral nervous system damage: A combination of myositis/ myasthenia overlap syndrome and motor axonal polyneuropathy

ARMAN ÇAKAR, IBRAHIM KAMACI, ELIF Kocasoy ORHAN, HACER DURMUŞ, YEŞIM PARMAN

Immune-checkpoint inhibitors (ICI) are effective drugs in cancer treatment that block immune checkpoints and stimulate an attack on cancer cells. However, various side effects were reported with ICIs. Peripheral nervous system (PNS) side effects are three times more frequent than those in the central nervous system. A 63-year-old male patient was admitted to our department with a 10-day history of dyspnea, diplopia, and generalized weakness.

ENG 2023;76(11-12)

Hypertension and nephrology

OCTOBER 30, 2023

[Chronic kidney disease and venous thromboembolic events]

VÁRADY Tímea, MÁCSAI Emília, SZLOVÁK Edina, DOLGOS Szilveszter

[Our aim is to analyse venous thromboembolic events regarding chronic kidney disease. Based upon epidemiologic data, both thromboembolic and haemorrhagic events are more frequent among patients with chronic kidney disease. Changes in levels of coagulant factors, thrombocyte and endothel disfunction, uremic toxins and dialysis related issues share role in pathogenesis. Guidelines lack of adequate information regarding this specific patient group. Therapeutic shift can be observed from vitamin K antagontists toward direct oral anticoagulants, not only in general population but also in CKD patients, with special interest in apixaban. Another therapeutic trend is change from unfractioned heparin to low molecular weigh heparins with anti Xa level monitoring among CKD population. Special attention is needed for thrombotic events related to eritropoietin therapy and hemodialysis access.]

HUN 2023;27(05)